InvestorsHub Logo

Nanotoday

10/31/17 11:07 AM

#135694 RE: leifsmith #135689

I disagree. $80M may seem low for drug development, but not to get to "this stage" which is no lead candidates, no ability to manufacture at a commercial or even testable scale, no CREDIBLE published results, and no product, yes, NO PRODUCT. That's where they are, and $80M gone, with +30% of that going to Diwan and management and family.

Looking back, that will all seem so clear and obvious, and yet, it eludes many.